The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule
Abstract
Fas is an apoptosis-signaling receptor molecule on the surface of a number of cell types. Molecular cloning and nucleotide sequence analysis revealed a human Fas messenger RNA variant capable of encoding a soluble Fas molecule lacking the transmembrane domain because of the deletion of an exon encoding this region. The expression of soluble Fas was confirmed by flow cytometry and immunocytochemical analysis. Supernatants from cells transfected with the variant messenger RNA blocked apoptosis induced by the antibody to Fas. Levels of soluble Fas were elevated in patients with systemic lupus erythematosus, and mice injected with soluble Fas displayed autoimmune features.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 2,885
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,737
Suda, T., Takahashi, T., Golstein, P., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90326-l · Cited by 2,489
Molecular cloning and expression of a receptor for human tumor necrosis factor
Schall, T. J., Lewis, M., Koller, K. J., Lee, A., Rice, G. C., Wong, G. H. W., Gatanaga, T., Granger, G. A., Lentz, R., Raab, H., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90816-w · Cited by 964
A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen
Itoh, N., & Nagata, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82075-0 · Cited by 839
Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., & Trauth, B. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50076-x · Cited by 834
The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
Watanabe-Fukunaga, R., Brannan, C. I., Itoh, N., Yonehara, S., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1274 · Cited by 815
Mosley, B., Beckmann, M. P., March, C. J., Idzerda, R. L., Gimpel, S. D., VandenBos, T., Friend, D., Alpert, A., Anderson, D., Jackson, J., et al. (1989) · Cell · doi:10.1016/0092-8674(89)90295-x · Cited by 624
Cited by
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
Reed, J. C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64779-7 · Cited by 1,288
Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
Apoptosis signaling by death receptors
Schulze‐Osthoff, K., Ferrari, D., Los, M., Wesselborg, S., & Peter, M. E. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540439.x · Cited by 978
Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease
Bogdan, A. R., Miyazawa, M., Hashimoto, K., & Tsuji, Y. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.11.012 · Cited by 893
The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell, J., O'Sullivan, G. C., Collins, J. K., & Shanahan, F. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1075 · Cited by 878
The machinery of programmed cell death
Zimmermann, K. C., Bonzon, C., & Green, D. R. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00159-0 · Cited by 833
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
David, C. J., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1973010 · Cited by 814
Teitz, T., Wei, T., Valentine, M. B., Vanin, E. F., Grenet, J., Valentine, V. A., Behm, F. G., Look, A. T., Lahti, J. M., & Kidd, V. J. (2000) · Nature Medicine · doi:10.1038/75007 · Cited by 811
Life and death by death receptors
Guicciardi, M. E., & Gores, G. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-111005 · Cited by 690
FAP-1: A Protein Tyrosine Phosphatase That Associates with Fas
Sato, T., Irie, S., Kitada, S., & Reed, J. C. (1995) · Science · doi:10.1126/science.7536343 · Cited by 683
ALTERNATIVE SPLICING OF PRE-mRNA: Developmental Consequences and Mechanisms of Regulation
Lopez, A. J. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.279 · Cited by 640
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
Walczak, H., & Krammer, P. H. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4840 · Cited by 628
Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
Mohme, M., Riethdorf, S., & Pantel, K. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.144 · Cited by 602
Regulation of Apoptosis by Alternative Pre-mRNA Splicing
Schwerk, C., & Schulze-Osthoff, K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.05.026 · Cited by 594
Fas and FasL in the homeostatic regulation of immune responses
Lynch, D. H., Ramsdell, F., & Alderson, M. R. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80079-4 · Cited by 558
Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases
Nakamura, T., Naguro, I., & Ichijo, H. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.06.010 · Cited by 523
Inhibition of Fas death signals by FLIPs
Tschopp, J., Irmler, M., & Thome, M. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80223-9 · Cited by 520
Maciejewski, J., Selleri, C., Anderson, S., & Young, N. (1995) · Blood · doi:10.1182/blood.v85.11.3183.bloodjournal85113183 · Cited by 476
Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
Wu, J., Wilson, J., He, J., Xiang, L., Schur, P. H., & Mountz, J. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118892 · Cited by 472
Self-citationImmune escape of tumors: apoptosis resistance and tumor counterattack
Igney, F. H., & Krammer, P. H. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.6.907 · Cited by 468
Torti, S. V., Manz, D. H., Paul, B. T., Blanchette-Farra, N., & Torti, F. M. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051732 · Cited by 426
DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection
Bigger, C. B., Brasky, K. M., & Lanford, R. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7059-7066.2001 · Cited by 442
The spliceosome as a target of novel antitumour drugs
Bonnal, S., Vigevani, L., & Valcárcel, J. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3823 · Cited by 405
CD95(APO-1/Fas)-Mediated Apoptosis: Live and Let Die
Krammer, P. H. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60402-2 · Cited by 394
Urbanski, L. M., Leclair, N., & Anczuków, O. (2018) · WIREs RNA · doi:10.1002/wrna.1476 · Cited by 389
Apoptosis in rheumatoid arthritis synovium.
Firestein, G. S., Yeo, M., & Zvaifler, N. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118202 · Cited by 383
Regulation of Fas Alternative Splicing by Antagonistic Effects of TIA-1 and PTB on Exon Definition
Izquierdo, J. M., Majós, N., Bonnal, S., Martínez, C., Castelo, R., Guigó, R., Bilbao, D., & Valcárcel, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.015 · Cited by 364
Nitric Oxide Inhibits Fas-induced Apoptosis
Mannick, J. B., Miao, X. Q., & Stamler, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24125 · Cited by 315
CD40-CD40 Ligand: A Multifunctional Receptor-Ligand Pair
Van Kooten, C., & Banchereau, J. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60865-2 · Cited by 311
The evolving roles of alternative splicing
Lareau, L. F., Green, R. E., Bhatnagar, R. S., & Brenner, S. E. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2004.05.002 · Cited by 310
Yun, T. J., Chaudhary, P. M., Shu, G. L., Frazer, J. K., Ewings, M. K., Schwartz, S. M., Pascual, V., Hood, L. E., & Clark3, E. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6113 · Cited by 307
Cytokines in Parkinson’s disease
Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Advances in Research on Neurodegeneration · doi:10.1007/978-3-7091-6284-2_12 · Cited by 308
The Role of Apoptosis in the Regulation of Trophoblast Survival and Differentiation during Pregnancy
Straszewski-Chavez, S. L., Abrahams, V. M., & Mor, G. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0003 · Cited by 307
Alternative splicing in cancer: implications for biology and therapy
Chen, J., & Weiss, W. A. (2015) · Oncogene · doi:10.1038/onc.2013.570 · Cited by 304
Liu, D., Kou, X., Chen, C., Liu, S., Liu, Y., Yu, W., Yu, T., Yang, R., Wang, R., Zhou, Y., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0070-2 · Cited by 298
Albertine, K. H., Soulier, M. F., Wang, Z., Ishizaka, A., Hashimoto, S., Zimmerman, G. A., Matthay, M. A., & Ware, L. B. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64455-0 · Cited by 288
The metastasis gene osteopontin: a candidate target for cancer therapy
Weber, G. F. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00037-3 · Cited by 286
The Apoptosis-Promoting Factor TIA-1 Is a Regulator of Alternative Pre-mRNA Splicing
Förch, P., Puig, O., Kedersha, N., Martínez, C., Granneman, S., Séraphin, B., Anderson, P., & Valcárcel, J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00107-6 · Cited by 284
Clinical significance of CD38 expression in chronic lymphocytic leukemia
Del Poeta, G., Maurillo, L., Venditti, A., Buccisano, F., Epiceno, A. M., Capelli, G., Tamburini, A., Suppo, G., Battaglia, A., Del Principe, M. I., et al. (2001) · Blood · doi:10.1182/blood.v98.9.2633 · Cited by 280
Prasad, N. K. A., Papoff, G., Zeuner, A., Bonnin, E., Kazatchkine, M. D., Ruberti, G., & Kaveri, S. V. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3781 · Cited by 279
Spaceflight alters microtubules and increases apoptosis in human lymphocytes (Jurkat)
Lewis, M. L., Reynolds, J. L., Cubano, L. A., Hatton, J. P., Lawless, B. D., & Piepmeier, E. H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.11.1007 · Cited by 277
The genetic regulation of apoptosis
Wyllie, A. H. (1995) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(95)90060-8 · Cited by 276
Heaney, M., & Golde, D. (1996) · Blood · doi:10.1182/blood.v87.3.847.bloodjournal873847 · Cited by 272
Interferon-γ Modulates a p53-independent Apoptotic Pathway and Apoptosis-related Gene Expression
Ossina, N. K., Cannas, A., Powers, V. C., Fitzpatrick, P. A., Knight, J. D., Gilbert, J. R., Shekhtman, E. M., Tomei, L. D., Umansky, S. R., & Kiefer, M. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16351 · Cited by 271
Self-citationApoptosis and hepatobiliary disease
Patel, T., & Gores, G. J. (1995) · Hepatology · doi:10.1002/hep.1840210635 · Cited by 264
Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer
Kędzierska, H., & Piekiełko-Witkowska, A. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.013 · Cited by 262
Tilgner, H., Jahanbani, F., Blauwkamp, T., Moshrefi, A., Jaeger, E., Chen, F., Harel, I., Bustamante, C. D., Rasmussen, M., & Snyder, M. P. (2015) · Nature Biotechnology · doi:10.1038/nbt.3242 · Cited by 223
A Native Soluble Form of CTLA-4
Oaks, M. K., Hallett, K. M., Penwell, R. T., Stauber, E. C., Warren, S. J., & Tector, A. J. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1649 · Cited by 256
Characterization of Structural Domains of Human Osteoclastogenesis Inhibitory Factor
Yamaguchi, K., Kinosaki, M., Goto, M., Kobayashi, F., Tsuda, E., Morinaga, T., & Higashio, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5117 · Cited by 200
Izquierdo, J. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800017200 · Cited by 156
CD95–CD95L: can the brain learn from the immune system?
Becher, B., Owens, T., Antel, J. P., & Barker, P. A. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01180-6 · Cited by 63
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Metadata
- Authors
- Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., & Mountz, J. D.
- Venue
- Science
- Published
- 1994-03-25
- Volume
- 263
- Issue
- 5154
- Pages
- 1759-1762
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1975336660
- Cited by
- 1,107
- References
- 17
- FWCI
- 21.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.